• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类肠道细胞系Caco-2中的二肽转运载体对头孢菌素头孢氨苄的摄取。

Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.

作者信息

Dantzig A H, Bergin L

机构信息

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285.

出版信息

Biochim Biophys Acta. 1990 Sep 7;1027(3):211-7. doi: 10.1016/0005-2736(90)90309-c.

DOI:10.1016/0005-2736(90)90309-c
PMID:2397233
Abstract

The transport of the orally absorbed cephalosporin, cephalexin, was examined in the human epithelial cell line, Caco-2 that possesses intestinal enterocyte-like properties when cultured. In sodium-free buffer, the cells accumulated 1 mM D-[9-14C]cephalexin against a concentration gradient and obtained a distribution ratio of 3.5 within 180 min. Drug uptake was maximal when the extracellular pH was 6.0. Uptake was reduced by metabolic inhibitors and by protonophores indicating that uptake was energy- and proton-dependent. Kinetic analysis of the concentration dependence of the rate of cephalexin uptake showed that a non-saturable component (Kd of 0.18 +/- 0.01 nmol/min per mg protein per mM) and a transport system with a Km of 7.5 +/- 2.8 mM and a Vmax of 6.5 +/- 0.9 nmol/min per mg protein were responsible for drug uptake. Uptake was competitively inhibited by dipeptides. The transport carrier exhibited stereospecificity for the L-isomer of cephalexin. Drug uptake was not affected by the presence of amino acids, organic anions, 4-acetamido-4'-isothiocyanostilbene-2,2'-disulfonic acid or 4,4'-diisothiocyano-2,2'-disulfonic stilbene. Therefore, Caco-2 cells take up cephalexin by a proton-dependent dipeptide transport carrier that closely resembles the transporter present in the intestine. Caco-2 cells represent a cellular model for future studies of the dipeptide transporter.

摘要

在人上皮细胞系Caco-2中研究了口服吸收的头孢菌素头孢氨苄的转运情况,该细胞系在培养时具有肠上皮细胞样特性。在无钠缓冲液中,细胞逆浓度梯度积累1 mM D-[9-¹⁴C]头孢氨苄,并在180分钟内获得3.5的分布比。当细胞外pH为6.0时,药物摄取量最大。代谢抑制剂和质子载体可降低摄取量,表明摄取是能量和质子依赖性的。头孢氨苄摄取速率的浓度依赖性动力学分析表明,一个非饱和成分(每毫克蛋白质每毫摩尔的Kd为0.18±0.01 nmol/min)和一个Km为7.5±2.8 mM、Vmax为每毫克蛋白质6.5±0.9 nmol/min的转运系统负责药物摄取。摄取受到二肽的竞争性抑制。转运载体对头孢氨苄的L-异构体表现出立体特异性。氨基酸、有机阴离子、4-乙酰氨基-4'-异硫氰基芪-2,2'-二磺酸或4,4'-二异硫氰基-2,2'-二磺酸芪的存在不影响药物摄取。因此,Caco-2细胞通过一种质子依赖性二肽转运载体摄取头孢氨苄,该载体与肠道中的转运体非常相似。Caco-2细胞代表了未来二肽转运体研究的细胞模型。

相似文献

1
Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.人类肠道细胞系Caco-2中的二肽转运载体对头孢菌素头孢氨苄的摄取。
Biochim Biophys Acta. 1990 Sep 7;1027(3):211-7. doi: 10.1016/0005-2736(90)90309-c.
2
Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake.头孢克洛通过人肠道Caco-2细胞的质子依赖性二肽转运载体的摄取及其与头孢氨苄摄取的比较。
Biochim Biophys Acta. 1992 Dec 9;1112(2):167-73. doi: 10.1016/0005-2736(92)90388-3.
3
Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management.正常及缺氧/复氧处理的Caco-2细胞中二肽转运体(PepT1)的激素调节
World J Gastroenterol. 2003 Apr;9(4):808-12. doi: 10.3748/wjg.v9.i4.808.
4
Carrier-mediated uptake of cephalexin in human intestinal cells.头孢氨苄在人肠道细胞中的载体介导摄取。
Biochem Biophys Res Commun. 1988 Sep 15;155(2):1082-7. doi: 10.1016/s0006-291x(88)80607-7.
5
Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells.碳头孢烯类与头孢菌素类的构效关系:抗菌活性及与Caco-2细胞肠道质子依赖性二肽转运载体的相互作用
Antimicrob Agents Chemother. 1997 Aug;41(8):1649-57. doi: 10.1128/AAC.41.8.1649.
6
Proton-driven dipeptide uptake in primary cultured rabbit conjunctival epithelial cells.原代培养兔结膜上皮细胞中质子驱动的二肽摄取
Invest Ophthalmol Vis Sci. 1998 Nov;39(12):2365-73.
7
Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.负责将氯碳头孢、头孢克肟和头孢呋辛酯吸收进入人肠道Caco-2细胞的转运机制。
Biochim Biophys Acta. 1994 Apr 20;1191(1):7-13. doi: 10.1016/0005-2736(94)90226-7.
8
Mechanism of riboflavine uptake by Caco-2 human intestinal epithelial cells.Caco-2人肠上皮细胞摄取核黄素的机制。
Am J Physiol. 1994 Jan;266(1 Pt 1):G15-21. doi: 10.1152/ajpgi.1994.266.1.G15.
9
Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.缬氨酸-缬氨酸-缬氨酸立体异构体在人肠上皮细胞系Caco-2中的代谢、摄取及跨上皮转运
Pharm Res. 1996 Nov;13(11):1663-7. doi: 10.1023/a:1016436606183.
10
Characteristics of ceftibuten uptake into Caco-2 cells.头孢布烯进入Caco-2细胞的特性。
Pharm Res. 1994 Dec;11(12):1761-5. doi: 10.1023/a:1018919517839.

引用本文的文献

1
Ceftazidime and cefepime antagonize 5-fluorouracil's effect in colon cancer cells.头孢他啶和头孢吡肟拮抗氟尿嘧啶对结肠癌细胞的作用。
BMC Cancer. 2022 Jan 31;22(1):125. doi: 10.1186/s12885-021-09125-4.
2
Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery.自纳米乳化药物递送系统:从开发到口服药物递送的当前应用与挑战
Pharmaceutics. 2020 Dec 9;12(12):1194. doi: 10.3390/pharmaceutics12121194.
3
Membrane Chemistry Tunes the Structure of a Peptide Transporter.
膜化学调节肽转运蛋白的结构。
Angew Chem Int Ed Engl. 2020 Oct 19;59(43):19121-19128. doi: 10.1002/anie.202008226. Epub 2020 Sep 11.
4
Conductance Changes in Bovine Serum Albumin Caused by Drug-Binding Triggered Structural Transitions.药物结合引发的结构转变导致牛血清白蛋白的电导变化。
Materials (Basel). 2019 Mar 28;12(7):1022. doi: 10.3390/ma12071022.
5
Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.改善药物通过肠黏膜和血脑屏障递送的途径与进展。
Ther Deliv. 2014 Oct;5(10):1143-63. doi: 10.4155/tde.14.67.
6
pH-Responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins.具有降低离子强度负载溶液的pH响应性聚(衣康酸-co-N-乙烯基吡咯烷酮)水凝胶为表现出高异电点的治疗性蛋白质提供了改善的口服递送潜力。
Int J Pharm. 2014 Aug 25;471(1-2):83-91. doi: 10.1016/j.ijpharm.2014.05.023. Epub 2014 May 20.
7
Distinguishing between the permeability relationships with absorption and metabolism to improve BCS and BDDCS predictions in early drug discovery.区分与吸收和代谢相关的渗透性,以改善早期药物发现中的BCS和BDDCS预测。
Mol Pharm. 2014 Apr 7;11(4):1335-44. doi: 10.1021/mp4007858. Epub 2014 Mar 28.
8
Pharmacokinetics of amino acid ester prodrugs of acyclovir after oral administration: interaction with the transporters on Caco-2 cells.阿昔洛韦氨基酸酯前药口服给药后的药代动力学:与Caco-2细胞上转运体的相互作用。
Int J Pharm. 2008 Oct 1;362(1-2):93-101. doi: 10.1016/j.ijpharm.2008.06.018. Epub 2008 Jun 27.
9
hPEPT1 is responsible for uptake and transport of Gly-Sar in the human bronchial airway epithelial cell-line Calu-3.人肽转运体1(hPEPT1)负责在人支气管气道上皮细胞系Calu-3中摄取和转运甘氨酰-肌氨酸。
Pflugers Arch. 2008 Jun;456(3):611-22. doi: 10.1007/s00424-007-0421-1. Epub 2007 Dec 20.
10
Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).磷酸二酯酶抑制剂对肠道hPepT1(溶质载体家族15成员1)活性的调节是通过抑制钠氢交换体3(溶质载体家族9成员3)实现的。
Biochim Biophys Acta. 2007 Jul;1768(7):1822-9. doi: 10.1016/j.bbamem.2007.04.006. Epub 2007 Apr 14.